Paolo Pucci's most recent trade in Merus N.V was a trade of 17,262 Share Option (right to buy) done . Disclosure was reported to the exchange on Dec. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merus N.V | Paolo Pucci | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 17,262 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 16,604 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 14,414 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 13,193 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 8,844 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 6,120 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | 22 May 2025 | 13,193 | 13,193 | - | - | Share Option (right to buy) | ||
| West Pharma Services | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 1,071 | 10,946 (0%) | 0% | 0 | Common Stock | |
| Replimune Grp Inc | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | 07 May 2024 | 8,844 | 8,844 | - | - | Share Option (right to buy) | ||
| West Pharma Services | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2024 | 564 | 9,875 (0%) | 0% | 0 | Common Stock | |
| Replimune Grp Inc | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | 08 Jun 2023 | 14,414 | 14,414 | - | - | Share option (right to buy) | ||
| West Pharma Services | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 616 | 9,311 (0%) | 0% | - | Common Stock | |
| Replimune Grp Inc | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 25,200 | 25,200 | - | - | Stock Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | 31 May 2022 | 16,604 | 16,604 | - | - | Share option (right to buy) | ||
| West Pharma Services | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 632 | 8,695 (0%) | 0% | - | Common Stock | |
| Replimune Grp Inc | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | 28 May 2021 | 6,120 | 6,120 | - | - | Share option (right to buy) | ||
| West Pharma Services | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 577 | 8,063 (0%) | 0% | - | Common Stock | |
| Replimune Grp Inc | Paolo Pucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 16,500 | 16,500 | - | - | Stock Option (right to buy) |